ECTRIMS 2013: Supporting patient engagement for optimized treatment management in MS

  • Satellite symposium 02-10-2013

    • ECTRIMS 2013

      There is more to caring for MS patients than prescribing drugs: The collaboration between clinical professionals and MS patients is vital. The patient should be engaged in decision making and clinicians should keep communicating and take note of their specific aims, hopes, and plans. These issues are discussed in detail by Prof. Mark S. Freedman, Dr. Anthony Feinstein, and Dr. Alessandra Lugaresi.

    • Anthony Feinstein - Understanding our patients: the importance of effective communication

    • Alessandra Lugaresi - Engaging with patients to achieve treatments goals

    • David Bates - Discussion: patient engagement with MS treatment

back to top

This online Resource Centre has been made possible by a donation from EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.

Note that EMD Serono, Inc. and Pfizer Inc have had no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein have been subject to an independent editorial review

Prof Timothy Vartanian

Prof Timothy Vartanian

Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell University, obtained his M.D. degree from the University of Chicago, Pritzker School of Medicine and his Ph.D. in Biochemistry and Molecular Biology from the ...

Read more »

Journal Editor's choice

Multiple Sclerosis and Related Disorders ; Volume 3, Issue 2

Prof. Gavin Giovannoni

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis
D.R. Altmann, K. Schmierer, K. Hunter, D.J. Tozer, C.A. Wheeler-Kingshott, A. Coles, D.H. Miller
Multiple Sclerosis and Related Disorders, April 2014, Vol 3 Issue 2.

Read more »

back to top